){kind=logo}
Loeb & Loeb partner John Settineri comments on new IRS tax rules that will tighten limits placed on inversion deals. He is quoted in connection with one of the largest tax inversion deals ever recorded – pharmaceutical giant Pfizer’s 2015 merger with Allergan.
Click here to read the article on the Law360 website.
Click here to read the article on the Law360 website.